File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Reduced substantia innominata volume mediates contributions of microvascular and macrovascular disease to cognitive deficits in Alzheimer's disease

TitleReduced substantia innominata volume mediates contributions of microvascular and macrovascular disease to cognitive deficits in Alzheimer's disease
Authors
KeywordsCerebrovascular disorders
Substantia innominata
Internal carotid artery diseases
Alzheimer's disease
Vascular dementia
Issue Date2018
Citation
Neurobiology of Aging, 2018, v. 66, p. 23-31 How to Cite?
Abstract© 2018 Elsevier Inc. The relationships between cholinergic system damage and cerebrovascular disease are not entirely understood. Here, we investigate associations between atrophy of the substantia innominata (SI; the origin of cortical cholinergic projections) and measures of large and small vessel disease; specifically, elongation of the juxtaposed internal carotid artery termination and Cholinergic Pathways Hyperintensity scores (CHIPS). The study (n = 105) consisted of patients with Alzheimer's disease (AD) and/or subcortical ischemic vasculopathy, and elderly controls. AD and subcortical ischemic vasculopathy groups showed greater impingement of the carotid termination on the SI and smaller SI volumes. Both carotid termination elongation and CHIPS were associated independently with smaller SI volumes in those with and without AD. Atrophy of the SI mediated effects of carotid termination elongation on language and memory functions and the effect of CHIPS on attention/working memory. In conclusion, SI atrophy was related to cerebrovascular disease of the large and small vessels and to cognitive deficits in people with and without AD.
Persistent Identifierhttp://hdl.handle.net/10722/289067
ISSN
2021 Impact Factor: 5.133
2020 SCImago Journal Rankings: 2.081
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorJaswal, Gurpreet-
dc.contributor.authorSwardfager, Walter-
dc.contributor.authorGao, Fu qiang-
dc.contributor.authorNestor, Sean M.-
dc.contributor.authorGanda, Anoop-
dc.contributor.authorCogo-Moreira, Hugo-
dc.contributor.authorSahlas, Demetrios J.-
dc.contributor.authorStuss, Donald T.-
dc.contributor.authorMoody, Alan-
dc.contributor.authorBlack, Sandra E.-
dc.date.accessioned2020-10-12T08:06:35Z-
dc.date.available2020-10-12T08:06:35Z-
dc.date.issued2018-
dc.identifier.citationNeurobiology of Aging, 2018, v. 66, p. 23-31-
dc.identifier.issn0197-4580-
dc.identifier.urihttp://hdl.handle.net/10722/289067-
dc.description.abstract© 2018 Elsevier Inc. The relationships between cholinergic system damage and cerebrovascular disease are not entirely understood. Here, we investigate associations between atrophy of the substantia innominata (SI; the origin of cortical cholinergic projections) and measures of large and small vessel disease; specifically, elongation of the juxtaposed internal carotid artery termination and Cholinergic Pathways Hyperintensity scores (CHIPS). The study (n = 105) consisted of patients with Alzheimer's disease (AD) and/or subcortical ischemic vasculopathy, and elderly controls. AD and subcortical ischemic vasculopathy groups showed greater impingement of the carotid termination on the SI and smaller SI volumes. Both carotid termination elongation and CHIPS were associated independently with smaller SI volumes in those with and without AD. Atrophy of the SI mediated effects of carotid termination elongation on language and memory functions and the effect of CHIPS on attention/working memory. In conclusion, SI atrophy was related to cerebrovascular disease of the large and small vessels and to cognitive deficits in people with and without AD.-
dc.languageeng-
dc.relation.ispartofNeurobiology of Aging-
dc.subjectCerebrovascular disorders-
dc.subjectSubstantia innominata-
dc.subjectInternal carotid artery diseases-
dc.subjectAlzheimer's disease-
dc.subjectVascular dementia-
dc.titleReduced substantia innominata volume mediates contributions of microvascular and macrovascular disease to cognitive deficits in Alzheimer's disease-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.neurobiolaging.2018.01.025-
dc.identifier.pmid29505952-
dc.identifier.scopuseid_2-s2.0-85042699512-
dc.identifier.volume66-
dc.identifier.spage23-
dc.identifier.epage31-
dc.identifier.eissn1558-1497-
dc.identifier.isiWOS:000431006300003-
dc.identifier.issnl0197-4580-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats